Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity.

about

Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity.

Item

http://www.wikidata.org/entity/Q55118987

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Combination Treatment of Icari ...... sioned Dopamine Neurotoxicity.

@en

Combination Treatment of Icari ...... sioned Dopamine Neurotoxicity.

@nl

type

Item

label

Combination Treatment of Icari ...... sioned Dopamine Neurotoxicity.

@en

Combination Treatment of Icari ...... sioned Dopamine Neurotoxicity.

@nl

prefLabel

Combination Treatment of Icari ...... sioned Dopamine Neurotoxicity.

@en

Combination Treatment of Icari ...... sioned Dopamine Neurotoxicity.

@nl

P1476

Combination Treatment of Icari ...... sioned Dopamine Neurotoxicity.

@en

P2093

Ce Chen

http://www.w3.org/2001/XMLSchema#string

Dai-Di Li

http://www.w3.org/2001/XMLSchema#string

Di-Sheng Lu

http://www.w3.org/2001/XMLSchema#string

Feng Zhang

http://www.w3.org/2001/XMLSchema#string

Guo-Qing Wang

http://www.w3.org/2001/XMLSchema#string

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Jingshan Shi

http://www.w3.org/2001/XMLSchema#string

Ya-Xin Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies

Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity

Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents.

Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's disease

Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations.

Dyskinesia: L-dopa-induced and tardive dyskinesia.

3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro.

Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.

Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.

Description of Parkinson's disease as a clinical syndrome.

P304

155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNMOL.2018.00155

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29867347

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

neurotoxicity

P932

5964195

http://www.w3.org/2001/XMLSchema#string